Preimplantation Genetic Testing Market Size, Trends, Analysis, and Outlook By Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), By Product (Reagents and Consumables, Instruments, Software and Services), By Application (Aneuploidy, Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing, Gender Identification), By Cycle (Fresh non-Donor, Frozen non-Donor, Fresh Donor, Frozen Donor), By End-User (Fertility Clinics, Hospitals, Diagnostic Laboratories, Others), by Country, Segment, and Companies, 2024-2032
The global Preimplantation Genetic Testing market size is poised to register 8.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Preimplantation Genetic Testing market across By Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), By Product (Reagents and Consumables, Instruments, Software and Services), By Application (Aneuploidy, Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing, Gender Identification), By Cycle (Fresh non-Donor, Frozen non-Donor, Fresh Donor, Frozen Donor), By End-User (Fertility Clinics, Hospitals, Diagnostic Laboratories, Others)
The future of the preimplantation genetic testing (PGT) market is influenced by advancements in reproductive genetics, increasing adoption of in vitro fertilization (IVF) techniques, and growing demand for genetic screening and embryo selection in assisted reproductive technology (ART) procedures. Preimplantation genetic testing encompasses a set of genetic screening techniques used by fertility specialists and embryologists to analyze embryos created through IVF for genetic abnormalities, chromosomal aneuploidies, and inherited genetic disorders before embryo transfer into the uterus to improve the success rate of IVF treatments and reduce the risk of miscarriage or genetic diseases in offspring. With the rise of delayed childbearing, infertility rates, and genetic testing options, there is a growing need for preimplantation genetic testing solutions that offer high accuracy, sensitivity, and reliability for comprehensive genetic analysis and embryo selection to help couples achieve successful pregnancies and healthy babies through IVF. Further, technological innovations such as next-generation sequencing (NGS), array comparative genomic hybridization (aCGH), and single-nucleotide polymorphism (SNP) microarray are driving the development of next-generation preimplantation genetic testing platforms with improved resolution, throughput, and cost-effectiveness for genetic diagnosis and counseling in ART clinics and fertility centers. Over the forecast period to 2030, expanding applications in infertility treatment, reproductive genetics, and prenatal screening, coupled with increasing demand for personalized fertility care and expanded genetic testing panels, are expected to drive market growth and innovation, enabling IVF clinics and fertility laboratories to offer advanced genetic screening services and improve reproductive outcomes for individuals and couples undergoing fertility treatment.
Preimplantation Genetic Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Preimplantation Genetic Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Preimplantation Genetic Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Preimplantation Genetic Testing industry.
Key market trends defining the global Preimplantation Genetic Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Preimplantation Genetic Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Preimplantation Genetic Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Preimplantation Genetic Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Preimplantation Genetic Testing industry
Leading Preimplantation Genetic Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Preimplantation Genetic Testing companies.
Preimplantation Genetic Testing Market Study- Strategic Analysis Review
The Preimplantation Genetic Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Preimplantation Genetic Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Preimplantation Genetic Testing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Preimplantation Genetic Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Preimplantation Genetic Testing market segments. Similarly, Strong market demand is encouraging Canadian Preimplantation Genetic Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Preimplantation Genetic Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Preimplantation Genetic Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Preimplantation Genetic Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Preimplantation Genetic Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Preimplantation Genetic Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Preimplantation Genetic Testing in Asia Pacific. In particular, China, India, and South East Asian Preimplantation Genetic Testing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Preimplantation Genetic Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Preimplantation Genetic Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Preimplantation Genetic Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Preimplantation Genetic Testing.
Preimplantation Genetic Testing Market Company Profiles
The global Preimplantation Genetic Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Agilent Technologies Inc, Illumina Inc, Oxford Nanopore Technologies Ltd, QIAGEN N.V., Revvity Health Inc, Takara Bio Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB.
Recent Preimplantation Genetic Testing Market Developments
The global Preimplantation Genetic Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Preimplantation Genetic Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Procedure
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
By Product
Reagents and Consumables
Instruments
Software and Services
By Application
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-Linked Disorders
HLA Typing
Gender Identification
By Cycle
Fresh non-Donor
Frozen non-Donor
Fresh Donor
Frozen Donor
By End-User
Fertility Clinics
Hospitals
Diagnostic Laboratories
Others
Geographical Segmentation:
Abbott Laboratories
Agilent Technologies Inc
Illumina Inc
Oxford Nanopore Technologies Ltd
QIAGEN N.V.
Revvity Health Inc
Takara Bio Inc
The Cooper Companies Inc
Thermo Fisher Scientific Inc
Vitrolife AB
Formats Available: Excel, PDF, and PPT
The future of the preimplantation genetic testing (PGT) market is influenced by advancements in reproductive genetics, increasing adoption of in vitro fertilization (IVF) techniques, and growing demand for genetic screening and embryo selection in assisted reproductive technology (ART) procedures. Preimplantation genetic testing encompasses a set of genetic screening techniques used by fertility specialists and embryologists to analyze embryos created through IVF for genetic abnormalities, chromosomal aneuploidies, and inherited genetic disorders before embryo transfer into the uterus to improve the success rate of IVF treatments and reduce the risk of miscarriage or genetic diseases in offspring. With the rise of delayed childbearing, infertility rates, and genetic testing options, there is a growing need for preimplantation genetic testing solutions that offer high accuracy, sensitivity, and reliability for comprehensive genetic analysis and embryo selection to help couples achieve successful pregnancies and healthy babies through IVF. Further, technological innovations such as next-generation sequencing (NGS), array comparative genomic hybridization (aCGH), and single-nucleotide polymorphism (SNP) microarray are driving the development of next-generation preimplantation genetic testing platforms with improved resolution, throughput, and cost-effectiveness for genetic diagnosis and counseling in ART clinics and fertility centers. Over the forecast period to 2030, expanding applications in infertility treatment, reproductive genetics, and prenatal screening, coupled with increasing demand for personalized fertility care and expanded genetic testing panels, are expected to drive market growth and innovation, enabling IVF clinics and fertility laboratories to offer advanced genetic screening services and improve reproductive outcomes for individuals and couples undergoing fertility treatment.
Preimplantation Genetic Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Preimplantation Genetic Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Preimplantation Genetic Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Preimplantation Genetic Testing industry.
Key market trends defining the global Preimplantation Genetic Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Preimplantation Genetic Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Preimplantation Genetic Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Preimplantation Genetic Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Preimplantation Genetic Testing industry
Leading Preimplantation Genetic Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Preimplantation Genetic Testing companies.
Preimplantation Genetic Testing Market Study- Strategic Analysis Review
The Preimplantation Genetic Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Preimplantation Genetic Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Preimplantation Genetic Testing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Preimplantation Genetic Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Preimplantation Genetic Testing market segments. Similarly, Strong market demand is encouraging Canadian Preimplantation Genetic Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Preimplantation Genetic Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Preimplantation Genetic Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Preimplantation Genetic Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Preimplantation Genetic Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Preimplantation Genetic Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Preimplantation Genetic Testing in Asia Pacific. In particular, China, India, and South East Asian Preimplantation Genetic Testing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Preimplantation Genetic Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Preimplantation Genetic Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Preimplantation Genetic Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Preimplantation Genetic Testing.
Preimplantation Genetic Testing Market Company Profiles
The global Preimplantation Genetic Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Agilent Technologies Inc, Illumina Inc, Oxford Nanopore Technologies Ltd, QIAGEN N.V., Revvity Health Inc, Takara Bio Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB.
Recent Preimplantation Genetic Testing Market Developments
The global Preimplantation Genetic Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Preimplantation Genetic Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Procedure
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
By Product
Reagents and Consumables
Instruments
Software and Services
By Application
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-Linked Disorders
HLA Typing
Gender Identification
By Cycle
Fresh non-Donor
Frozen non-Donor
Fresh Donor
Frozen Donor
By End-User
Fertility Clinics
Hospitals
Diagnostic Laboratories
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
Agilent Technologies Inc
Illumina Inc
Oxford Nanopore Technologies Ltd
QIAGEN N.V.
Revvity Health Inc
Takara Bio Inc
The Cooper Companies Inc
Thermo Fisher Scientific Inc
Vitrolife AB
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Preimplantation Genetic Testing Market Overview and Key Findings, 2024
1.2 Preimplantation Genetic Testing Market Size and Growth Outlook, 2021- 2030
1.3 Preimplantation Genetic Testing Market Growth Opportunities to 2030
1.4 Key Preimplantation Genetic Testing Market Trends and Challenges
1.4.1 Preimplantation Genetic Testing Market Drivers and Trends
1.4.2 Preimplantation Genetic Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Preimplantation Genetic Testing Companies
2. PREIMPLANTATION GENETIC TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Preimplantation Genetic Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Preimplantation Genetic Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PREIMPLANTATION GENETIC TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PREIMPLANTATION GENETIC TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Procedure
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
By Product
Reagents and Consumables
Instruments
Software and Services
By Application
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-Linked Disorders
HLA Typing
Gender Identification
By Cycle
Fresh non-Donor
Frozen non-Donor
Fresh Donor
Frozen Donor
By End-User
Fertility Clinics
Hospitals
Diagnostic Laboratories
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Preimplantation Genetic Testing Market, 2025
5.2 Asia Pacific Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Preimplantation Genetic Testing Market, 2025
5.5 Europe Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Preimplantation Genetic Testing Market, 2025
5.8 North America Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Preimplantation Genetic Testing Market, 2025
5.11 South America Pacific Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Preimplantation Genetic Testing Market, 2025
5.14 Middle East Africa Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Preimplantation Genetic Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Preimplantation Genetic Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Preimplantation Genetic Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Preimplantation Genetic Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Preimplantation Genetic Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Preimplantation Genetic Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Preimplantation Genetic Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Preimplantation Genetic Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Preimplantation Genetic Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Preimplantation Genetic Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Preimplantation Genetic Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Preimplantation Genetic Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Preimplantation Genetic Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Preimplantation Genetic Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Preimplantation Genetic Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Preimplantation Genetic Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Preimplantation Genetic Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Preimplantation Genetic Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Preimplantation Genetic Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Preimplantation Genetic Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Preimplantation Genetic Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Preimplantation Genetic Testing Industry Drivers and Opportunities
7. PREIMPLANTATION GENETIC TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PREIMPLANTATION GENETIC TESTING COMPANY PROFILES
8.1 Profiles of Leading Preimplantation Genetic Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Agilent Technologies Inc
Illumina Inc
Oxford Nanopore Technologies Ltd
QIAGEN N.V.
Revvity Health Inc
Takara Bio Inc
The Cooper Companies Inc
Thermo Fisher Scientific Inc
Vitrolife AB.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Preimplantation Genetic Testing Market Overview and Key Findings, 2024
1.2 Preimplantation Genetic Testing Market Size and Growth Outlook, 2021- 2030
1.3 Preimplantation Genetic Testing Market Growth Opportunities to 2030
1.4 Key Preimplantation Genetic Testing Market Trends and Challenges
1.4.1 Preimplantation Genetic Testing Market Drivers and Trends
1.4.2 Preimplantation Genetic Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Preimplantation Genetic Testing Companies
2. PREIMPLANTATION GENETIC TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Preimplantation Genetic Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Preimplantation Genetic Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PREIMPLANTATION GENETIC TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PREIMPLANTATION GENETIC TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Procedure
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Comparative Genomic Hybridization
Single-Nucleotide Polymorphism
By Product
Reagents and Consumables
Instruments
Software and Services
By Application
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-Linked Disorders
HLA Typing
Gender Identification
By Cycle
Fresh non-Donor
Frozen non-Donor
Fresh Donor
Frozen Donor
By End-User
Fertility Clinics
Hospitals
Diagnostic Laboratories
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Preimplantation Genetic Testing Market, 2025
5.2 Asia Pacific Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Preimplantation Genetic Testing Market, 2025
5.5 Europe Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Preimplantation Genetic Testing Market, 2025
5.8 North America Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Preimplantation Genetic Testing Market, 2025
5.11 South America Pacific Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Preimplantation Genetic Testing Market, 2025
5.14 Middle East Africa Preimplantation Genetic Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Preimplantation Genetic Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Preimplantation Genetic Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Preimplantation Genetic Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Preimplantation Genetic Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Preimplantation Genetic Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Preimplantation Genetic Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Preimplantation Genetic Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Preimplantation Genetic Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Preimplantation Genetic Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Preimplantation Genetic Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Preimplantation Genetic Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Preimplantation Genetic Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Preimplantation Genetic Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Preimplantation Genetic Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Preimplantation Genetic Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Preimplantation Genetic Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Preimplantation Genetic Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Preimplantation Genetic Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Preimplantation Genetic Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Preimplantation Genetic Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Preimplantation Genetic Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Preimplantation Genetic Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Preimplantation Genetic Testing Industry Drivers and Opportunities
7. PREIMPLANTATION GENETIC TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PREIMPLANTATION GENETIC TESTING COMPANY PROFILES
8.1 Profiles of Leading Preimplantation Genetic Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Agilent Technologies Inc
Illumina Inc
Oxford Nanopore Technologies Ltd
QIAGEN N.V.
Revvity Health Inc
Takara Bio Inc
The Cooper Companies Inc
Thermo Fisher Scientific Inc
Vitrolife AB.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
